← The Wire
FATENasdaq
FATE THERAPEUTICS INC
Biological Products, (No Diagnostic Substances) · CIK 1434316
Develops off-the-shelf cellular immunotherapies from engineered stem cells for broad patient access
red 8-K · 90d
$240M
Market cap
$2.42
Last close
+15.2%
1D
+12.6%
5D
5.9M
Volume
Price · last 39 sessions+34.4%
May 4L $1.73 · H $2.84Jun 29
249
Total filings
Jun 15, 2026
Last filing
12/31
Fiscal year end
424B5424B5Mar 20, 2024424B5424B5Jan 7, 2021424B5424B5Jan 4, 2021424B5424B5Jun 10, 2020424B5424B5Jun 8, 2020424B5424B5Sep 13, 2019424B5424B5Sep 11, 2019424B5424B5Sep 21, 2018424B5424B5Sep 20, 2018424B5424B5Dec 13, 2017424B5424B5Dec 12, 2017424B5424B5May 21, 2015424B5424B5May 18, 2015
Insider Activity
In the 90 days to Jan 9, 2026: 2 sold $17K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 9, 2026 | Tahl CindySee Remarks | Sell | 10,589 | $1.06 | $11K |
| Jan 9, 2026 | Valamehr BahramPresident and CEO | Sell | 5,190 | $1.07 | $6K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance